ACHIN SHARMA: Open Payments
NPI 1093715641 · HORN LAKE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 66 payments from 19 companies in 2025. Trend: 2023 $1,374 · 2024 $1,656 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $278 |
| Corcept Therapeutics | 4 | $262 |
| Novo Nordisk Inc | 8 | $147 |
| Abbott Laboratories | 3 | $143 |
| ABBVIE INC. | 9 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Lilly USA, LLC | 4 | $62 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| PFIZER INC. | 2 | $40 |
Products named: Korlym, FREESTYLE LIBRE 3, FARXIGA, AIRSUPRA, JARDIANCE, LINZESS, Ozempic, GEMTESA.
Industry payments across MS — which companies pay providers there.
